for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

JCU Corp

4975.T

Latest Trade

3,095.00JPY

Change

35.00(+1.14%)

Volume

126,800

Today's Range

3,080.00

 - 

3,140.00

52 Week Range

1,300.00

 - 

3,140.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
3,060.00
Open
3,110.00
Volume
126,800
3M AVG Volume
2.89
Today's High
3,140.00
Today's Low
3,080.00
52 Week High
3,140.00
52 Week Low
1,300.00
Shares Out (MIL)
27.04
Market Cap (MIL)
86,214.68
Forward P/E
19.12
Dividend (Yield %)
1.49

Next Event

Q3 2020 JCU Corp Earnings Release

Latest Developments

More

Jcu Corp Says To Buy Back Up To 3.77 Percent Of Own Shares Worth 1.5 Billion Yen Through May 31

JCU to set up wine unit in Hokkaido

JCU announces change of president

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About JCU Corp

JCU CORPORATION is a Japan-based company mainly engaged in the manufacture and sale of surface treatment agents and equipment. The Company operates in three business segments. The Agents segment provides decorative or rustproof coating agents for automotive components, water faucets and construction materials, as well as coating agents for printed circuit boards (PCBs), electronic parts and semiconductors. The Equipment segment provides automated surface treatment equipment and filtration machinery for automobile, printed circuit boards industries. The New Business segment is engaged in the sale of etching and cleaning equipment of PCBs using plasma technology, the sale of solar power generators and others.

Industry

Chemical Manufacturing

Contact Info

16F, TIXTOWER UENO, 4-8-1, Higashi-Ueno

+81.3.68957001

https://www.jcu-i.com/

Executive Leadership

Ryoichi Kimizuka

President, Chief Operating Officer, Chief Technology Officer, Representative Director

Keiji Ozawa

Vice Chairman of the Board, Representative Director

Masashi Kimura

Senior Managing Director, Senior Managing Executive Officer, Chief Director of Administration, Director of General Affairs, Manager of Business Strategy Office

Kenji Nakamura

Senior Managing Director, Senior Managing Executive Officer, Chief Director of Drug Business

Shinji Hayashi

Managing Director, Managing Executive Officer, Director of General Research Institute

Key Stats

2.67 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

0.0K

2018

0.0K

2019

0.0K

2020(E)

0.0K
EPS (JPY)

2017

147.550

2018

176.310

2019

178.550

2020(E)

161.833
Price To Earnings (TTM)
19.17
Price To Sales (TTM)
3.92
Price To Book (MRQ)
3.37
Price To Cash Flow (TTM)
17.11
Total Debt To Equity (MRQ)
6.80
LT Debt To Equity (MRQ)
4.11
Return on Investment (TTM)
16.57
Return on Equity (TTM)
13.97

Latest News

Latest News

Japan stocks edge down, earnings caution stops recent gains

Japan's Nikkei index surrendered modest gains to end lower on Tuesday, snapping a three-day rally as the market digested a slew of corporate earnings.

Japan stocks little changed, earnings caution stalls recent advance

Japan's Nikkei share average handed back earlier modest gains and stood little changed on Tuesday, with a three-day winning run stalling as the market digested a series of corporate earnings.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up